Results 231 to 240 of about 106,528 (297)

Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study. [PDF]

J Dermatol
Koyama A, Li L, Yamamoto T, Taira H, Sugimoto E, Ito Y, Mizuno Y, Awaji K, Tateishi S, Kanda H, Sato S, Shibata S.   +11 more
europepmc   +1 more source

Managing Monitoring: Biologic Therapy for Psoriasis

JEADV Clinical Practice, EarlyView.
Claudine Howard‐James, Eimear Gilhooley   +1 more
wiley   +1 more source

Health‐Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Vitiligo is a disorder characterized by depigmentation of the skin and is known to impact patients' health‐related quality of life (HRQoL). In Japan, HRQoL studies on vitiligo remain limited in size and scope, and factors contributing to impaired HRQoL, as well as the psychological burden, have not been adequately evaluated.
Naoki Oiso, Yasutaka Mizoro, Kazumasa Kamei, Kenichi Yamanaka, Masato Hoshi, Kouki Nakamura   +5 more
wiley   +1 more source

Criteria for Identifying Candidates for Systemic Psoriasis Treatment in the Real World: Application of the International Psoriasis Council Guidelines in Patients in North America. [PDF]

J Psoriasis Psoriatic Arthritis
Strober B, Zhong Y, Sima A, Beeghly A, Eckmann T, Balagula E, Zhuo J, Lebwohl M.   +7 more
europepmc   +1 more source

Pathogenesis of Vitiligo: Integrating Immune and Non‐Immune Cell Crosstalk

The Journal of Dermatology, EarlyView.
ABSTRACT Vitiligo is an acquired autoimmune disease characterized by depigmented macules resulting from melanocyte loss. It is a complex multifactorial disorder in which genetic predisposition is combined with environmental factors; however, its detailed etiology remains unclear.
Shintaro Inoue
wiley   +1 more source

Adapting the Goeckerman Regimen for Psoriasis Treatment in Kenya: A Case Study of Successful Management in a Resource-Limited Setting. [PDF]

Psoriasis (Auckl)
Smith P, Kranyak A, Johnson CE, Haran K, Muraguri Snr I, Maurer T, Bhutani T, Liao W, Kiprono S.   +8 more
europepmc   +1 more source

Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series

The Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) essentially exhibits dysbiosis of skin fungal microbiome, mycobiome, characterized by depletion of Malassezia. The effects of recent systemic therapies for AD on skin mycobiome were not understood enough. We examined changes of skin mycobiome before and after systemic treatments with anti‐IL‐4Rα antibody (dupilumab: DUP)
Yuta Koike, Hitomi Morisaki, Daisuke Motooka, Mai Matsumoto, Motoi Takenaka, Hiroyuki Murota   +5 more
wiley   +1 more source

Topical Delivery of microRNA-125b by Framework Nucleic Acids for Psoriasis Treatment. [PDF]

Int J Nanomedicine
Han Y, Xi L, Leng F, Xu C, Zheng Y.
europepmc   +1 more source

Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management

The Journal of Dermatology, EarlyView.
ABSTRACT The stratum corneum, as the outermost layer of the skin, functions as a critical barrier that maintains cutaneous hydration and systemic homeostasis. Among its structural lipids, ceramides constitute the most abundant and diverse component. These molecules are essential for the formation of lamellar structures that secure barrier integrity ...
Takashi Sakai
wiley   +1 more source

Erythrodermic psoriasis treatment with Guselkumab: report of two cases and literature review. [PDF]

An Bras Dermatol
Welsh E, Cardenas-de la Garza JA, García-Lozano JA, Flores-Gutierrez DP.   +3 more
europepmc   +1 more source